Skip to main content
OpenTrials
Completed

NCT Number: NCT04524572

The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses

The purpose of this prospective randomized controlled trial is to explore the role of a motion sensor with accompany web application on step counts, energy balance, and metabolic markers in nurses. Additionally, eating behaviours, behavioural regulation in exercise, and mood states that may impact these parameters will also be examined.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Risk Factor Behavior Cardiovascular Diseases Motor Activity

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Ottawa Heart Institute

Ottawa, Ontario, K1Y4W7, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1. Participant must be a registered nurse with the University of Ottawa Heart Institute;
  • Participant must be 18 years of age or older;
  • Participant must be able to walk unassisted;
  • Participant is able and willing to provide informed consent.

Exclusion criteria

  • Participant is pregnant, lactating or planning to become pregnant during the study period;
  • Participant is unable to read and understand English;
  • Medical contraindications to exercise;
  • Already using a motion sensor device to track physical activity. -

Treatment and study plan

Motion sensor

Behavioral

To explore the role of a motion sensor with accompanying web application on step counts, energy balance, and metabolic markers in nurses

Primary outcomes

  1. Step counts

    Time frame: 6 weeks during observation and 6 weeks during intervention

    All participants will be asked to wear a Tractivity® motion sensor device on their ankle for to assess their daily step count and physical activity energy expenditure

Secondary outcomes

  1. Body Mass (kg)

    Time frame: Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52

    Body weight will be measured using a digital scale to the nearest 0.1 kilogram

  2. Waist Circumference

    Time frame: Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52

    Waist circumference will be measured using a tape measure

  3. Fat mass

    Time frame: Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52

    Fat mass will be measured using bioelectrical impedance analysis

Sponsors and collaborators

Lead sponsor

Ottawa Heart Institute Research Corporation

Other

Registry information

Acronym: WALK

Important dates

Study start
2013
Primary completion
2014
Study completion
2015
First posted
Aug 24, 2020
Registry last updated
Sep 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.